GlassScriptPhysician profile
Jeremy N Meisel
NPI 1679513865
$7,464.64
in general payments reported to CMS, 2019-2025
51 companies · $1,770 in 2025
The $1,770 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $854 · 2020: $733 · 2021: $799 · 2022: $906 · 2023: $915 · 2024: $1,487 · 2025: $1,770.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,059 · Education: $112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,059.40 |
| Education | $111.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $981.08 | 2021-2025 | |
| Pfizer INC. | $566.58 | 2023-2025 | |
| Supernus Pharmaceuticals, INC. | $494.59 | 2019-2022 | |
| Harmony Biosciences LLC | $427.90 | 2023-2025 | Wakix |
| Jazz Pharmaceuticals INC. | $417.77 | 2019-2025 | |
| Teva Pharmaceuticals USA, INC. | $372.96 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Biogen, INC. | $326.79 | 2019-2025 | Vumerity, Leqembi, Tysabri |
| Lilly USA, LLC | $287.47 | 2019-2025 | Emgality, Amyvid, Kisunla |
| Sk Life Science, INC. | $260.00 | 2020-2024 | |
| Lundbeck LLC | $257.42 | 2019-2025 | Vyepti |
| Eisai INC. | $244.98 | 2020-2025 | |
| Ucb, INC. | $227.45 | 2024-2025 | Rystiggo, Nayzilam, Zilbrysq |
| Alexion Pharmaceuticals, INC. | $205.40 | 2019-2025 | Ultomiris |
| Sumitomo Pharma America, INC. | $191.21 | 2023-2024 | Aptiom |
| Neurelis, INC. | $130.63 | 2021-2024 | Valtoco |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeremy Meisel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.